AbbVie
ABBV
#30
Rank
NZ$530.26 B
Marketcap
$300.07
Share price
0.10%
Change (1 day)
20.91%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$237.72 Billion

According to AbbVie's latest financial reports the company's total liabilities are NZ$237.72 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$196.57 B2.71%
2022-12-31NZ$191.39 B-0.28%
2021-12-31NZ$191.92 B0.74%
2020-12-31NZ$190.52 B31.89%
2019-12-31NZ$144.45 B42.92%
2018-12-31NZ$101.07 B9.28%
2017-12-31NZ$92.49 B4.24%
2016-12-31NZ$88.73 B23.67%
2015-12-31NZ$71.74 B118.13%
2014-12-31NZ$32.89 B9.4%
2013-12-31NZ$30.06 B4.6%
2012-12-31NZ$28.74 B195.59%
2011-12-31NZ$9.72 B38.11%
2010-12-31NZ$7.04 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$219.66 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$132.35 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$106.07 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$144.27 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$62.54 B-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.69 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$103.30 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$110.97 B-53.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$1.41 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA